Spots Global Cancer Trial Database for oncology comparison study
Every month we try and update this database with for oncology comparison study cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission | NCT00962767 | Leukemia, Myelo... | gemtuzumab ozog... ATRA plus 6-MP ... | 18 Years - 61 Years | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission | NCT00962767 | Leukemia, Myelo... | gemtuzumab ozog... ATRA plus 6-MP ... | 18 Years - 61 Years | Wyeth is now a wholly owned subsidiary of Pfizer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
